Shanghai Fudan-Zhangjian Bio-Pharm (1349.HK) Q1 2023 Earnings

Apr 26Expected
Apr 2022
Aug 2022
Oct 2022
Q1 2023
-0.05
-0
0.04
0.08

Details

Expected EPS
0
Actual EPS
0
Surprise EPS
0
Surprise Percent
N/A

Description

⁨Shanghai Fudan-Zhangjian Bio-Pharm⁩ (⁦1349.HK⁩) has reported earnings of ⁦0⁩ per share for ⁦Q1 2023⁩.

0 Comments

Share your thoughts